Anti-IgE therapy with omalizumab decreases endothelin-1 in exhaled breath condensate of patients with severe persistent allergic asthma (Q84501314)
Jump to navigation
Jump to search
scientific article published on 26 June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-IgE therapy with omalizumab decreases endothelin-1 in exhaled breath condensate of patients with severe persistent allergic asthma |
scientific article published on 26 June 2010 |
Statements
Anti-IgE therapy with omalizumab decreases endothelin-1 in exhaled breath condensate of patients with severe persistent allergic asthma (English)